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Despite the high prevalence of pelvic inflammatory dis-
ease and uterine leiomyomas in women, an intramy-
ometrial abscess is a rare gynecological infection. Since
1945, only 22 cases of pyomyoma have been docu-
mented in the literature and confirmed by postmortem
or postoperative pathological examinations. All patients
had predisposed risk factors such as a gynecological
operation, pregnancy, vascular insufficiency, or immun-
odeficiency [1]. We herein present a case of a woman
with no known risk factors for tumor-associated infec-
tions and briefly review other cases previously reported
in the literature.
A 46-year-old woman who had experienced three
cesarean sections, G3P3, was admitted for a hysterec-
tomy. She had a history of an asymptomatic uterine
leiomyoma for 10 years without regular follow-up exam-
inations. The last clinical evaluation was done in 2004,
1 week following a cesarean delivery, at which time her
ultrasound examination showed no specific findings
except for a homogenous uterine tumor, 9 cm in diam-
eter. According to the patient’s statements and previous
medical records, she formerly had a regular menstrual
cycle with normal flow. Two weeks before this admis-
sion, she reported an intermittent low-grade fever which
was accompanied by mild rhinorrhea without abdom-
inal pain or pelvic discomfort. She suspected that it was
due to a common cold and so she did not take any med-
ication. The patient sought evaluation at our hospital
due to an episode of heavy menstrual flow and severe
dysmenorrhea. Pelvic examination revealed a non-tender,
fixed mass at 16 weeks’ gestation, with no abnormal dis-
charge from the cervix. Transabdominal ultrasound
revealed a tumor, measuring 14.3 × 12 × 8 cm, including
a cystic configuration located over the anterior lower
segment of the uterus (Figure 1). Lab data from the first
visit to our clinic also showed mild leukocytosis (white
blood cells = 13 × 109/L) and anemia (hemoglobin =
7.9 mg/dL). Due to diagnosis of a uterine leiomyoma
and abnormal uterine bleeding, a total abdominal hys-
terectomy was arranged and performed in November
2006.
During the laparotomy, adhesions between the
uterus and abdominal wall were observed. A tumor was
located over the anterior lower segment of the uterus,
which was tightly adherent to the bladder and pelvic
sidewall. The tumor mass was well circumscribed with
a capsule without extension or communication to the
endometrial cavity. While dissecting the mass, the tumor
ruptured and emitted a malodorous purulent fluid. 
A culture of the purulent discharge was obtained intra-
operatively. Due to the necrotic character of the mass,
malignancy was suspected, and the specimen was
immediately sent for pathological frozen section exam-
ination. However, the preliminary pathological exami-
nation indicated a uterine abscess without neoplastic
changes (Figures 2 and 3). The abdominal cavity was
irrigated with a large amount of normal saline solution
before the wound was surgically closed. After the oper-
ation, the patient presented with a persistent tempera-
ture elevation to 38°C and a low systolic pressure of
around 95 mmHg. Blood cultures were done before
experimental antibiotic treatment was begun. The
complete blood cell count with differential classifica-
tion (white blood cells=22 × 109/L; segment = 86%,
band = 2%) and C-reactive protein (12.37 mg/dL) were
determined during hospitalization. The fever subsided
3 days after intensive care, a blood transfusion, and
broad-spectrum antibiotic treatment using cefazoline,
gentamycin, and clindamycin. The cultures from the
pus demonstrated growth of Escherichia coli 5 days after
the operation and we adjusted the antibiotics based
on a bacterial sensitivity test. The patient responded
well to surgery and antibiotic treatment, and was dis-
charged on the eighth day after the operation. The
patient returned to our outpatient department 10
days after the operation for follow-up. The lab data
were all within normal limits and the surgical wound
was healing well.
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Figure 1. Abdominal sonography shows a midline sagittal section of the myoma and uterus (arrowhead). Note the significant
hypoechogenicity in the upper portion of the myoma (arrow) compared with the cystic lesion of the gross specimen.
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Figure 2. (A) Uterus fixed in formalin seen laterally, revealing the remaining capsule (arrow) of the tumor after a myomec-
tomy. There is a well-circumscribed myoma located over the anterior wall of the uterus. No obvious communication between
tumor and endometrial cavity was evident. (B) The myoma dissected from the anterior wall of the uterus. The cystic lesion
with tissue necrosis was localized in the upper part of the myoma (arrow). The cut surface of the tumor was whitish to yellow-
ish in color, with a whorled trabecular pattern.
An ordinary leiomyoma of the uterus is the most
common neoplasm, and pelvic infection is not rare in
women of a reproductive age. However, the appearance
of massive inflammatory cell infiltration in a leiomyoma
is a rare clinical event. A pyomyoma is rarely reported
and can be a lethal complication of a uterine leiomyoma.
We reviewed the literature and found that only 22 cases
have been reported since 1945. We list and briefly
describe the reports chronologically (Table) [1–22].
Although there are several hypotheses, the definitive
cause of a pyomyoma remains unclear. All cases can be
explained by the hypothesis of infection following tumor
necrosis/ischemia [3]. According to the literature, the
offending organisms are diverse (including Clostridium
spp., Staphylococcus aureus, Streptococcus milleri, Str. hemo-
lyticus, Str. agalactiae, Proteus spp., Serratia marcescens,
Actinomyces meyeri, Enterococcus faecalis, Edwardsiella tarda,
Klebsiella pneumonia, and Candida parapsilosis), but infection
routes can be ascending, by contiguous spread, or by
seeding from distant sites with lymphatic or hematoge-
nous spread [2]. Regardless of the size or location, the
tumor can potentially become infected, and an early
diagnosis of a pyomyoma is difficult due to the lack of
specific findings from imaging studies. Upon analyzing
the characteristics of all reported cases according to age
and etiology, three categories were determined: post-
menopausal; pregnancy-related; and pre-menopausal
pyomyomas [3].
Necrosis of a leiomyoma occurs in postmenopausal
women, especially in those with diabetes mellitus,
hypertension, atherosclerosis, or vascular insufficiency
(1 patient had third-stage uterine prolapse), and even
though this event is not rare, only eight cases of pyomy-
oma have been reported. One patient received conserva-
tive antibiotics for 10 days and then underwent surgery
but died 8 hours after surgery [4]. Another patient with
diabetes mellitus and hypertension presented with
septic shock and died 45 minutes after admission [5].
Ten case reports indicated that pregnancy might in-
crease the risk of a pyomyoma, but a cesarean section
might not increase the risk of infection. The conditions
of uterine instrumentation, such as abortions [6–8],
cesarean sections [9], and intravenous drug abuse [10]
are additional factors or possible routes of infection.
Caution must be taken if a patient with a uterine tumor
experiences severe abdominal pain, signs of infection,
and preterm labor. Immediate intervention and intensive
care are crucial. A pyomyoma occurring in all four pre-
menopausal women, not including our patient, can be
explained as secondary infections of the tumor following
a medical procedure such as cystoscopy [11] or intra-
uterine device insertion [12], or in the presence of severe
systemic diseases [13] like choledocholithiasis and pan-
creatitis. In a case reported by Greenspoon et al [1], a
49-year-old woman with a uterine leiomyoma used a folk
prescription of apricot juice injected by herself and re-
fused surgical intervention. The infection route was sim-
ilar to that seen with intravenous drug use. This patient
eventually died due to the delay in initiating medication
and surgery. Compared to those cases, our patient was
relatively healthy. The only risk factor for impaired im-
munity was anemia, which is commonly seen in women
with leiomyoma and hypermenorrhea. To our knowl-
edge, this is the only case without clear etiology of a
pyomyoma at a premenopausal age.
The mortality rate associated with pyomyomas is
high (3 of the 22 cases died), the clinical course is
rapid, and conservative treatments yield unsatisfactory
results. The decision to proceed with a hysterectomy or
myomectomy should take into consideration the desire
for fertility and clinical severity [14]. Compared with the
etiology mentioned in previous reports, our patient was
relatively healthy and did not have a previous surgical
history within the last 2 years. The operative findings
and pathological studies neither showed a sinus tract
between the endometrial cavity nor provided evidence of
a source of infection. The nonspecific clinical symptoms
and signs increase the difficulty of early detection for
this dangerous complication. Young or premenopausal
patients who undergo surgery without delay plus inten-
sive care and broad-spectrum antibiotic treatment can
result in a significantly improved outcome.
In conclusion, a pyomyoma is a life-threatening med-
ical condition. Whether asymptomatic uterine tumors
with degenerative changes require immediate surgery
or not is controversial. Our case presented with a uterine
tumor and sepsis, but no obvious source of infection [1],
therefore surgical treatment was expeditiously introduced
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Figure 3. Hematoxylin and eosin-stained section of the
leiomyoma shows massive inflammatory cell infiltration in
the leiomyoma without malignant change (original magnifi-
cation, × 400).
Taiwan J Obstet Gynecol • September 2010 • Vol 49 • No 3354
Z.H.Y. Chen, et al
Ta
bl
e.
B
rie
f s
um
m
ar
y 
of
 c
as
es
 r
ep
or
te
d 
in
 th
e 
lit
er
at
ur
e 
si
nc
e 
19
45
A
ut
ho
r
Ye
ar
A
ge
 
U
nd
er
ly
in
g 
co
nd
iti
on
Pr
es
en
ta
tio
n
Tr
ea
tm
en
t
Pa
th
og
en
C
om
pl
ic
at
io
n/
O
ut
co
m
e
(y
r)
M
ill
er
 [
4]
19
45
51
C
on
ge
st
iv
e 
he
ar
t f
ai
lu
re
, 
Fe
ve
r,
 s
ep
si
s
Su
lfa
di
az
in
e.
 S
ub
to
ta
l 
St
re
pt
oc
oc
cu
s h
em
ol
yt
icu
s
R
up
tu
re
d 
py
om
yo
m
a 
ut
er
in
e 
pr
ol
ap
se
, 
hy
st
er
ec
to
m
y+
B
SO
ca
us
ed
 p
er
ito
ni
tis
/d
ie
d 
m
en
op
au
se
af
te
r t
he
 o
pe
ra
tio
n
B
ed
ro
si
n 
19
56
50
N
ep
hr
ol
ith
ia
si
s,
 c
ys
to
sc
op
y,
 
Se
ps
is
, a
cu
te
 
Te
tr
ac
yc
lin
e.
 T
A
H
+
B
SO
C
ol
ifo
rm
 g
ro
up
Pe
rit
on
iti
s/
cu
re
d
et
 a
l [
11
] 
pr
em
en
op
au
sa
l 
ab
do
m
in
al
 p
ai
n
D
ub
oi
s 
&
 
19
57
29
3 
w
k 
po
st
pa
rt
um
 
Fe
ve
r,
 
Pe
ni
ci
lli
n
+
st
re
pt
om
yc
in
+
N
ot
 m
en
tio
ne
d
C
ur
ed
N
eu
m
m
an
 [
15
]
ab
do
m
in
al
 p
ai
n
ox
yt
et
ra
cy
cl
in
e.
 V
ag
in
al
 
m
yo
m
ec
to
m
y
R
uc
h 
[1
6]
19
63
34
Le
io
m
yo
m
a,
 
Pe
rs
is
te
nt
 fe
ve
r,
 
Pe
ni
ci
lli
n
+
se
pt
om
yc
in
. 
G
ra
m
-p
os
iti
ve
 c
oc
ci
Pr
et
er
m
 d
el
iv
er
y,
 
pr
et
er
m
 la
bo
r 
ab
do
m
in
al
 p
ai
n
TA
H
+
B
SO
pe
rit
on
iti
s/
cu
re
d
K
au
fm
an
n 
19
74
58
Le
io
m
yo
m
a,
 h
yp
er
te
ns
io
n,
 
H
em
ol
ys
is
, 
Pe
ni
ci
lli
n
C
lo
st
rid
iu
m
 p
er
fr
in
ge
ns
D
ie
d 
(d
ue
 to
 
et
 a
l [
5]
 
di
ab
et
es
 m
el
lit
us
, 
se
pt
ic
 s
ho
ck
de
la
ye
d 
tr
ea
tm
en
t)
m
en
op
au
se
W
ei
ss
 e
t a
l [
2]
19
76
59
D
ia
be
te
s,
 m
en
op
au
se
A
cu
te
 a
bd
om
en
Pe
ni
ci
lli
n
+
st
re
pt
om
yc
in
. 
C
lo
st
rid
iu
m
sp
., 
A
bd
om
in
al
 w
al
l 
TA
H
+
B
SO
En
te
ro
ba
ct
er
ia
ce
ae
, 
fi
st
ul
iz
at
io
n/
cu
re
d
St
re
pt
oc
oc
cu
ss
p.
Fu
lle
r &
 
19
86
68
N
o 
sy
st
em
ic
 d
is
ea
se
, h
ug
e 
Lo
w
er
 e
xt
re
m
ity
 
TA
H
+
B
SO
St
re
pt
oc
oc
cu
ss
p.
C
ur
ed
La
w
re
nc
e 
[1
7]
ut
er
in
e 
tu
m
or
, m
en
op
au
se
ed
em
a 
fo
r 2
 m
o
Pr
ic
ha
rd
 e
t a
l [
6]
19
86
37
Le
io
m
yo
m
a,
 s
po
nt
an
eo
us
 
9 
w
k 
po
st
-a
bo
rt
io
n,
 
Pe
ni
ci
lli
n
+
st
re
pt
om
yc
in
. 
St
re
pt
oc
oc
cu
s m
ill
er
i
En
do
ca
rd
iti
s/
cu
re
d
ab
or
tio
n 
at
 2
0 
w
k
fe
ve
r,
 p
el
vi
c 
te
nd
er
ne
ss
TA
H
+
B
SO
W
on
g 
et
 a
l [
7]
19
86
29
In
tr
au
te
rin
e 
de
vi
ce
, 
Po
st
-a
bo
rt
io
n 
se
ps
is
A
m
pi
ci
lli
n
+
ge
nt
am
yc
in
. 
St
ap
hy
lo
co
cc
us
 a
ur
eu
s,
 
R
ig
ht
 o
va
ria
n 
ve
in
 th
ro
m
bo
si
s,
 
sp
on
ta
ne
ou
s 
ab
or
tio
n 
TA
H
+
B
SO
 
Se
rr
at
ia
 m
ar
ce
sc
en
s
he
m
at
op
er
ito
ne
um
/c
ur
ed
G
re
en
sp
oo
n 
19
90
49
Le
io
m
yo
m
a,
 
In
te
rm
itt
en
t f
ev
er
 
G
en
ta
m
yc
in
+
St
ap
hy
lo
co
cc
us
 a
ur
eu
s,
 
Se
pt
ic
 s
ho
ck
, e
nd
oc
ar
di
tis
/
et
 a
l [
1]
pr
em
en
op
au
sa
l, 
ap
ric
ot
 
fo
r 3
 w
k,
 c
hi
lls
, 
cl
in
da
m
yc
in
+
am
pi
ci
lli
n
A
ct
in
om
yc
es
, E
nt
er
oc
oc
cu
ss
p.
di
ed
 (
pa
tie
nt
 w
as
 
ju
ic
e 
se
lf-
in
je
ct
io
n
ab
do
m
in
al
 p
ai
n
ag
ai
ns
t s
ur
ge
ry
)
Ya
ng
 &
 W
an
g 
[1
3]
19
99
46
C
ho
le
do
ch
ol
ith
ia
si
s
Pa
nc
re
at
iti
s
A
m
ik
ac
in
 s
w
itc
he
d 
to
 
Ed
wa
rd
sie
lla
 ta
rd
a
C
ur
ed
IV
 c
ef
ox
iti
n,
 T
A
H
+
B
SO
Taiwan J Obstet Gynecol • September 2010 • Vol 49 • No 3 355
Idiopathic, Life-threatening Pyomyoma
To
bi
as
 e
t a
l [
8]
 
19
96
32
El
ec
tiv
e 
ab
or
tio
n
Po
st
-a
bo
rt
io
n 
fe
ve
r,
 
C
ef
ox
iti
n,
 a
m
pi
ci
lli
n
+
En
te
ro
co
cc
us
 fa
ec
al
is
Pe
rit
on
iti
s/
cu
re
d
ab
do
m
in
al
 p
ai
n
ge
nt
am
yc
in
+
m
et
ro
ni
da
zo
le
. 
TA
H
+
B
SO
 
Pr
ah
lo
w
 e
t a
l [
10
]
19
96
31
Pr
eg
na
nc
y,
 IV
 d
ru
g 
ab
us
e
A
bd
om
in
al
 p
ai
n
A
m
pi
ci
lli
n
+
cl
in
da
m
yc
in
+
St
ap
hy
lo
co
cc
us
 a
ur
eu
s
Pe
rit
on
iti
s/
cu
re
d
az
tr
eo
na
m
. T
A
H
+
B
SO
G
up
ta
 e
t a
l [
18
] 
19
99
75
N
ot
 m
en
tio
ne
d
Fe
ve
r,
 a
bd
om
in
al
 p
ai
n
A
nt
ib
io
tic
s.
 T
A
H
+
B
SO
St
re
pt
oc
oc
cu
ss
pp
.
C
ur
ed
G
en
ta
 e
t a
l [
3]
20
01
60
Le
io
m
yo
m
a,
 d
ia
be
te
s,
 
A
bd
om
in
al
 m
as
s,
 
Pe
ni
ci
lli
n
+
am
ik
ac
in
. 
St
re
pt
oc
oc
cu
s a
ga
la
ct
ia
e
En
do
ca
rd
iti
s,
 d
ee
p 
ve
in
 
m
en
op
au
se
an
or
ex
ia
, f
ev
er
 
TA
H
+
B
SO
th
ro
m
bo
si
s/
cu
re
d
G
ru
ne
 e
t a
l [
14
] 
20
01
44
Le
io
m
yo
m
a,
 p
re
gn
an
cy
Fe
ve
r
A
nt
ib
io
tic
s.
 C
/S
+
K
le
bs
ie
lla
 p
ne
um
on
ia
e
Se
ps
is
/c
ur
ed
m
yo
m
ec
to
m
y
Li
n 
et
 a
l [
9]
 
20
02
33
Le
io
m
yo
m
a,
 p
re
gn
an
cy
Pr
et
er
m
 la
bo
r,
 
A
nt
ib
io
tic
s.
 T
A
H
B
lo
od
 c
ul
tu
re
:
Pe
rit
on
iti
s,
 s
ep
tic
 s
ho
ck
, 
po
st
pa
rt
um
 w
ou
nd
 
Es
ch
er
ich
ia
 co
li,
 p
us
 c
ul
tu
re
: 
w
ou
nd
 in
fe
ct
io
n/
cu
re
d
in
fe
ct
io
n,
 a
bd
om
in
al
 p
ai
n
ca
nd
id
a
K
ar
ca
al
tin
ca
ba
 &
 
20
03
36
Le
io
m
yo
m
a,
 p
re
gn
an
cy
Fe
ve
r,
 a
bd
om
in
al
 p
ai
n
A
nt
ib
io
tic
s.
 M
yo
m
ec
to
m
y
Pe
pt
os
tr
ep
to
co
cc
us
 te
tr
ad
ru
s
Py
om
yo
m
a 
ru
pt
ur
e,
 
Su
da
ko
ff
 [
19
] 
pe
rit
on
iti
s/
cu
re
d
M
an
so
n 
et
 a
l [
20
] 
20
05
29
Le
io
m
yo
m
a.
 3
 w
k 
Fe
ve
r,
 a
bd
om
in
al
 p
ai
n,
 
A
m
pi
ci
lli
n
+
ge
nt
am
ic
in
+
N
o 
gr
ow
th
C
ur
ed
af
te
r v
ag
in
al
 d
el
iv
er
y
dy
su
ria
m
et
ro
ni
da
zo
le
. M
yo
m
ec
to
m
y
Ye
at
 e
t a
l [
21
] 
20
05
53
Le
io
m
yo
m
a,
 m
en
op
au
se
Fe
ve
r,
 a
bd
om
in
al
 p
ai
n
C
ef
m
et
az
ol
e 
to
 c
ef
tiz
ox
im
e
+
Pr
ot
eu
s m
ira
bi
lis
Py
om
yo
m
a 
ru
pt
ur
e,
 
m
et
ro
ni
da
zo
le
. T
A
H
+
B
SO
pe
rit
on
iti
s/
cu
re
d
Sa
h 
et
 a
l [
22
] 
20
05
64
H
ug
e 
ut
er
in
e 
le
io
m
yo
m
a,
 
Fe
ve
r,
 a
bd
om
in
al
 p
ai
n
A
nt
ib
io
tic
s.
 T
A
H
+
B
SO
St
ap
hy
lo
co
cc
us
 a
ur
eu
s
C
ur
ed
m
en
op
au
se
M
an
ch
an
a 
20
07
42
Le
io
m
yo
m
a,
 IU
D
, 
Fe
ve
r,
 a
bd
om
in
al
 p
ai
n
A
nt
ib
io
tic
s.
 T
A
H
+
B
SO
N
o 
gr
ow
th
C
ur
ed
et
 a
l [
12
] 
pr
em
en
op
au
sa
l
Pr
es
en
t c
as
e
43
Le
io
m
yo
m
a,
 
Fe
ve
r,
 h
yp
er
m
en
or
rh
ea
C
ef
az
ol
in
e
+
ge
nt
am
yc
in
+
Es
ch
er
ich
ia
 co
li
C
ur
ed
pr
em
en
op
au
sa
l
cl
in
da
m
yc
in
. T
A
H
TA
H
=
to
ta
l a
bd
om
in
al
 h
ys
te
re
ct
om
y;
 B
SO
=
bi
la
te
ra
l s
al
pi
ng
o-
oo
ph
or
ec
to
m
y;
 C
/S
=
ce
sa
re
an
 se
ct
io
n;
 IU
D
=
in
tr
au
te
rin
e 
de
vi
ce
.
before severe sepsis or death occurred. We herein report
a relatively healthy premenopausal woman with an
idiopathic pyomyoma to remind clinicians of this rare
disease and the need for rapid intervention.
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